We found that EP300-mutated cancers more highly expressed immune (such as cytokine–cytokine receptor interaction and Jak–STAT signaling), oncogenic (such as cell cycle), and DDR (such as p53 signaling) pathways (Figure 3). Here, EP300 is linked to cancer.